Viewing Study NCT04176328


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-03-02 @ 3:43 PM
Study NCT ID: NCT04176328
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2019-11-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Sponsor: Neupharma Srl
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cystic Fibrosis View
None Methicillin-resistant Staphylococcus aureus View
None Teicoplanin View